'Promising' oral antiviral drug vs COVID-19 now on Phase 3 clinical trial at Lung Center

'Promising' oral antiviral drug vs COVID-19 now on Phase 3 clinical trial at Lung Center

Bibliografiset tiedot
Julkaisussa:Manila Bulletin Vol. 584, no. 7 (07 Aug. 2021), 2
Päätekijä: Luci, Charissa M.
Aineistotyyppi: Artikkeli
Julkaistu: 2021
Aiheet:
Molnupiravir (Antiviral drug)
Clinical trials > Lung Center of the Philippines
COVID-19 treatment